Compare with another brand → · RSS
TumoRx
TumoRx has 51 on-market SKUs in the DSLD, first entered 2013-11-25. 41.2% of its products declare at least one proprietary blend, and 0.0% of all its all-time SKUs are now off-market.
51
on-market SKUs
41.2%
with a blend
0.0%
gummies
0.0%
off-market churn
Report card
- Median dose adequacy (elemental dose ÷ studied low dose, pooled across compounds): 1.2917
- % with a third-party certification statement (USP/NSF/Informed Sport/GMP, as asserted on label): 0.0%
- Average excipient count per product: 1
- First entry: 2013-11-25 · Latest entry: 2013-12-24
Compared with the median brand
Context for the numbers above: the same measures for the median of the 1,430 brands with at least 10 on-market products. A difference from the median is a description, not a grade; a specialty brand can sit far from the median for good reasons.
| Measure | TumoRx | Median brand |
|---|---|---|
| Products with a proprietary blend | 41.2% | 26.7% |
| Products in an exact Formula Twins cluster | 7.8% | 10% |
| Products declaring a dose above an adult UL | 0% | 0% |
| Products listing a synthetic FD&C dye | 0% | 0% |
| Products listing titanium dioxide | 0% | 0% |
| Gummies | 0% | 0% |
| Products with a certification statement | 0% | 0% |
| Average excipients per product | 1 | 4.5 |
| All-time SKUs now off-market | 0% | 15.4% |
What it sells
- Capsule: 48 (94.1%)
- Powder: 1 (2.0%)
- Liquid: 1 (2.0%)
- Softgel Capsule: 1 (2.0%)
Compounds declared most often
- Bromelain: 7 products
- Coenzyme Q10: 5 products
- Alpha-Lipoic Acid: 3 products
- Methylsulfonylmethane (MSM): 2 products